This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how ...
Additional oral presentations explore odronextamab in areas of high unmet need, including the primary analysis in diffuse large B-cell lymphoma progressing after CAR-T therapy and first results in ...
NORTH CHICAGO, Ill., Dec. 2, 2025 /PRNewswire/ -- AbbVie today announced it will unveil new data at the 2025 American Society of Hematology (ASH) Congress, showcasing continued advances in research ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback